PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Subdivisions of Program Areas, these track general higher level sub-classifications of expenditure.
Subdivisions of Major categories, these are the most detailed expenditure data.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2010
The overall objective of the Kenya Pharma project is to establish and operate a safe, secure, reliable and sustainable supply chain management system to forecast, quantify, procure, store and distribute pharmaceuticals, supplies and equipment needed to provide care and treatment of persons with HIV/AIDS in Kenya.
The strategy is to become more cost efficient over time. The project is constantly seeking opportunities to increase its cost efficiency through improved freight forwarding and improved delivery operations. The project also operates a competitive tender process for HIV/AIDS commodities with low cost being the most heavily weighted selection criterion.
Over time, a second strategy is to transition to the partner government, local organization or other donor. The Kenya Pharma project has sustainability as one of its overall program goals and is structured to maximize the use of Kenyan institutions and individuals in its provision of services. Kenya Pharma has been working with local suppliers and testing laboratories to increase the capacity of these institutions. Kenya Pharma is also in the process of becoming ISO 9001 certified to create a complete documentary file of operations for the use of any successor organization. Kenya Pharma has previously purchased 3 vehicles but does not plan to purchase any in FY12. This activity supports GHI/LLC and is funded primarily through pipeline funds in this budget cycle.
The Kenya Pharma project procures OI drugs for provision to implementing care and support programs within Kenya. The programs operate mostly at the facility level and target the spectrum of HIV/AIDS populations. The project supplies national coverage both through direct distribution and through stock sharing with the GoK-supported distribution system. The commodity aspects of the programs are continually monitored and evaluated using data collected from regular monthly facility-level patient, stock, and distribution reports; internal distribution records from the Kenya Pharma project; and direct customer feedback from partners and service providers (collected through a network of Kenya Pharma field representatives).
Resources requested in this budget area directly support the Let's Live Campaign to ensure that orphans and vulnerable children due to HIV/AIDS have access to zinc tablets. These resources will be coupled with those from other accounts which will support other children (who do not fall into the OVC category) to receive similar services across targeted areas.
The Kenya Pharma project procures ARVs consistent with the nationally recommended guidelines for the provision of PMTCT. All ARVs are, of course, USFDA tentatively or fully approved and also registered with the Kenya Pharmacy and Poisons Board. The project participates as an active member of the Commodity Security Committee (coordinated by NASCOP, the Kenyan HIV/AIDS coordinating body) and participates in national quantification and procurement planning exercises. The project is coordinating and collaborating with other members of the supply chain community to improve the data associated with the location and client populations of PMTCT service providers and also to put in place mechanisms to ensure that these data can be maintained in a sustainable manner in the future.
The Kenya Pharma project procures the entire list of nationally recommended first line and second line ARVs for both adult and pediatric use. All ARVs are, of course, USFDA tentatively or fully approved and also registered with the Kenya Pharmacy and Poisons Board. The project also procures a limited list of OI drugs (antibiotics, antifungals, etc.) and drugs for co-infected TB patients. The project participates as an active member of the Commodity Security Committee (coordinated by NASCOP, the Kenyan HIV/AIDS coordinating body) and participates in national quantification and procurement planning exercises. There have been no stockouts of ARVs provided by the project in the last year and the project actively monitors stocks at all levels of the supply chain and coordinates among other members of the supply chain and among implementing partners to avoid future stockouts.